Want to join the conversation?
Thousand Oaks, California-based $AMGN said in total it is expecting on the order of 80 new launches across its countries and products in 2016. Repatha is launching now in Japan, Brazil and multiple countries in Europe and the early signs are good. Kyprolis is off to a strong early start in its first markets in Europe.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.